-
Adequate SIRT activity dose is as important as adequate chemotherapy dose - Authors' reply.
Journal article
Sharma RA. et al, (2017), Lancet Oncol, 18
-
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
Journal article
Wasan HS. et al, (2017), Lancet Oncol, 18, 1159 - 1171
-
FOXFIRE-SIRFLOX-FOXFIRE global prospective randomised studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer: KRAS mutation and tumour site analysis
Conference paper
Wasan H. et al, (2017), ANNALS OF ONCOLOGY, 28
-
Overall survival analysis of the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer
Conference paper
Virdee PS. et al, (2017), Annals of Oncology
-
Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials-ESORT).
Journal article
Odutayo A. et al, (2017), BMJ, 356
-
Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial.
Journal article
Hopewell S. et al, (2016), BMC Med, 14
-
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.
Journal article
Domingo E. et al, (2016), Lancet Gastroenterol Hepatol, 1, 207 - 216
-
The use of Bayesian design in two trials in rare cancers
Conference paper
Dutton PJ. et al, (2015), 16